⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL218382 | 0.56 | — | — | |
| SCHEMBL20241417 | 0.56 | — | — | |
| SCHEMBL1131068 | 0.56 | — | — | |
| SCHEMBL12547933 | 0.56 | — | — | |
| SCHEMBL4405963 | 0.56 | — | — | |
| SCHEMBL3604722 | 0.56 | — | — | |
| SCHEMBL4872506 | 0.56 | — | — | |
| SCHEMBL381363 | 0.54 | — | — | |
| Hydrochloric Acid SCHEMBL30929599 | 0.53 | — | — | |
| SCHEMBL2219735 | 0.53 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007077333-A2 | USE OF A NEUROPEPTIDE Y ANTAGONIST FOR DAMAGED OR SENSITIVE LIPS | L'OREAL (FR) | 2007-07-12 | — | — | WO | claimed |
| US-5807875-A | OBESITY THERAPY | DR. KARL THOMAE GMBH (DE) | 1998-09-15 | — | — | US | claimed |
| US-5616620-A | HYPOTENSIVE AGENTS | KARL THOMAE GMBH (DE) | 1997-04-01 | — | — | US | claimed |
| JP-H08505862-A | — | — | 1996-06-25 | — | — | JP | claimed |
| EP-0680469-A1 | AMINOACID DERIVATES, MEDICAMENTS CONTAINING THESE COMPOUNDS AND PROCESS FOR PREPARING THE SAME | Dr. Karl Thomae GmbH (DE) | 1995-11-08 | — | — | EP | claimed |
| WO-1994017035-A1 | AMINOACID DERIVATES, MEDICAMENTS CONTAINING THESE COMPOUNDS AND PROCESS FOR PREPARING THE SAME | DR. KARL THOMAE GMBH (DE) | 1994-08-04 | — | — | WO | claimed |
| EP-1919469-B1 | PROCESS FOR PREPARING AN ANGIOTENSIN II RECEPTOR ANTAGONIST | FARMAPROJECTS S A (ES) | 2011-02-16 | — | — | EP | disclosed |
| US-20080281097-A1 | Process for Preparing an Angiotensin II Receptor Antagonist | FARMAPROJECTS, S. A. (ES) | 2008-11-13 | — | — | US | disclosed |
| EP-1093803-B1 | Cosmetic composition comprising an antagonist of the neuropeptide Y receptor | SANOFI AVENTIS (FR) | 2008-09-17 | — | — | EP | disclosed |
| EP-1919469-A2 | PROCESS FOR PREPARING AN ANGIOTENSIN II RECEPTOR ANTAGONIST | Farmaprojects, S.A. (ES) | 2008-05-14 | — | — | EP | disclosed |
| WO-2007077333-A2 | USE OF A NEUROPEPTIDE Y ANTAGONIST FOR DAMAGED OR SENSITIVE LIPS | L'OREAL (FR) | 2007-07-12 | — | — | WO | disclosed |
| WO-2007017469-A2 | PROCESS FOR PREPARING AN ANGIOTENSIN II RECEPTOR ANTAGONIST | FARMAPROJECTS, S. A. (ES) | 2007-02-15 | — | — | WO | disclosed |
| EP-1749828-A1 | Process for preparing an angiotensin II receptor antagonist | FARMAPROJECTS S.L. (ES) | 2007-02-07 | — | — | EP | disclosed |
| US-5827853-A | MIXTURE CONTAINING PRODUCT FROM FERMENTATION BY STREPTOMYCES FOR TOPICAL APPLICATION TO SKIN OR HAIR, TO IMPROVE TEXTURE, SURFACE SMOOTHNESS, FIRMNESS | SANOFI (FR) | 1998-10-27 | — | — | US | disclosed |
| US-5807875-A | OBESITY THERAPY | DR. KARL THOMAE GMBH (DE) | 1998-09-15 | — | — | US | disclosed |
| EP-0838217-A2 | Cosmetic composition containing neuropeptide Y receptor antagonist | SANOFI (FR) | 1998-04-29 | — | — | EP | disclosed |
| EP-0824535-A1 | ANTIBACTERIAL CEPHALOSPORINS | BIOCHEMIE GESELLSCHAFT M.B.H. (AT) | 1998-02-25 | — | — | EP | disclosed |
| US-5616620-A | HYPOTENSIVE AGENTS | KARL THOMAE GMBH (DE) | 1997-04-01 | — | — | US | disclosed |
| EP-0680469-A1 | AMINOACID DERIVATES, MEDICAMENTS CONTAINING THESE COMPOUNDS AND PROCESS FOR PREPARING THE SAME | Dr. Karl Thomae GmbH (DE) | 1995-11-08 | — | — | EP | disclosed |
| WO-1994017035-A1 | AMINOACID DERIVATES, MEDICAMENTS CONTAINING THESE COMPOUNDS AND PROCESS FOR PREPARING THE SAME | DR. KARL THOMAE GMBH (DE) | 1994-08-04 | — | — | WO | disclosed |